Johnson & Johnson recently announced plans to invest more than $2 billion in a new manufacturing facility in North Carolina. The company plans to build a state-of-the-art biologics manufacturing facility in Wilson, North Carolina, to expand the production of its pipeline of innovative biologics. The expansion supports J&J’s broader plan to advance more than 70…

Roche recently announced it opened its latest Pharma Research and Early Development (pRED) Center in Basel Switzerland. The new facility is equipped with cutting-edge technologies and houses around 1,000 laboratory and office workspaces, according to the company. It is located at the company’s global headquarters and brings together teams of scientists and researchers to accelerate…

Mispro this week announced it will open its tenth Boston facility in December. The contract vivarium organization’s newest Boston-based facility will be located on Binney Street in Kendall Square, Cambridge, Massachusetts. The company said that Kendall Square has been recognized as a biotechnology and pharmaceutical innovation hub. Mispro’s latest facility will have turnkey vivarium lab…

Eugia Pharma Specialties’ manufacturing hub in India has received an FDA warning letter based on inspections of its facility. The new warning letter is tied to previous warnings about the company’s Unit III Formulation manufacturing facility. The unit makes terminally sterilized products. Eugia’s Hyderabad, India-based facility received an official action indicated (OAI) status notice in…

Novo Nordisk today announced plans to invest $4.1 billion to build a new manufacturing facility in North Carolina. The Denmark-based company will build a second fill and finishing manufacturing facility in Clayton, North Carolina, to grow its ability to produce current and future injectable treatments for people with obesity and other serious chronic diseases. Novo…

Emergent BioSolutions this week announced it entered into a definitive agreement to sell its Baltimore-Camden drug product facility. The Gaithersburg, Maryland-based company will sell the facility to an affiliate of Bora Pharmaceuticals for approximately $30 million. Emergent’s Camden site is part of the company’s Contract Development and Manufacturing Organization (CDMO) and has clinical and commercial…

Thermo Fisher Scientific has expanded its clinical research laboratory building at its good manufacturing practices (GMP) lab in Middleton, Wisconsin. The new $58 million investment adds 72,500 sq ft. to the company’s footprint and increases the site’s chemistry, manufacturing, and control analytical capabilities for biopharmaceutical therapy development. “As research in biopharmaceutical therapies continues to rapidly…

Vetter recently announced it is expanding its development services sites in the U.S. and is planning for major investments in Germany. The company announced plans to move and expand its Development Services site from Skokie, Illinois, to Des Plaines, Illinois. It plans to invest majorly in its commercial business in Saarland, Germany, to complement its…

Molecular Devices recently announced it opened its custom-built bioanalytical site in the U.K. The new facility is based in Cardiff, Wales, and is custom-built for the company’s bioprocess workflow and unique bioreactor technology. Molecular Devices’ biotechnology allows pharmaceutical companies to manufacture patient-derived organoids (PDOs) at scale in a quality-controlled manner. “Molecular Devices is the only…

Lotte Biologics and Merck recently signed a strategic partnership deal for biopharmaceutical manufacturing and process development. Through the agreement, Merck and Lotte Biologics will ensure the supply of essential raw materials and solutions for biopharmaceutical development and production, establish a stable supply chain system for raw materials, and develop a support system for the Bio…